IDIBAPS’ Inflammation and repair in respiratory diseases group is part of the collaborative RESPIRE-EXCEL project coordinated by Martijn Nawijn from1
Akantior: a recently approved drug for the treatment of acanthamoeba keratitis. The parasite infects the cornea through contact lenses and can cause1
The Clínic-IDIBAPS has coordinated a study that examines the natural history and the prognostic factors of porto-sinusoidal vascular disorder (PSVD),1
Researchers from the Clínic-IDIBAPS, along with researchers from the Dana Farber Cancer Institute (DFCI) in Boston, have published a review on dual H1
A Clínic-IDIBAPS research team is participating in the European Foreum-RA-Flare project, which aims to predict relapses in patients with rheumatoid a1
Dr. Joan Giralt has been part of the Clínic family for almost 17 years now… and for 12 years has been a professor of ophthalmology at the Faculty of1
Metabolic fatty liver disease affects almost 30% of the population, and 80% of those who are obese. The disease has no cure, but its progression can1
Last Tuesday, 15 October 2024, IDIBAPS received a visit from thirty people, most of them patients with liver cancer under treatment at the Hospital C1
It is the first time that a public research foundation reaches this figure anywhere in Spain.
Prehabilitation is the preparation of a patient before undergoing surgery. Taking physical exercise and improving your diet and other habits before s1
